image 7
image 2
image 6
image 4
image 1
image 8
image 3
image 5

The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research"

Professor Karl Skorecki

Ms. Ruth Alon

Position:Director

Ruti Alon joined Pitango in 1997. With over 30 years of international experience in the high-tech medical industry and heads the life sciences activities at Pitango.

Ruti previously worked on Wall Street where she held senior positions with Montgomery Securities and Kidder Peabody & Co as a senior medical device analyst.

Ruti was the founder and Chairperson of ILSI, an umbrella organization representing approximately 750 Israeli life sciences companies. Currently, she sits on the Board of IATI – Israel Advanced Technologies Industry - an organization presenting the Israeli high-tech industry, created via a merger of ILSI with HTIA.

Ruti previously served on the Boards of ColBar, acquired by Johnson& Johnson, Disc-O-Tech acquired by Kyphon and Ventor acquired by Medtronic (NYSE: MDT)

She is currently is the Chairperson of the Boards of BioControl and BrainsGate. In addition, she is a member of the Boards of numerous Pitango portfolio companies including, BetaO2, HealOr, Vascular Biogenics (VBL), AposTherapy and CarboFix.

Copyright � 2014 BioRap Technologies LTD. All Rights Reserved. Created by Catom web design